These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6973859)

  • 41. Non-MHC-linked genetic control of murine cytotoxic T lymphocyte responses to hapten-modified syngeneic cells.
    Arora PK; Shearer GM
    J Immunol; 1981 Nov; 127(5):1822-8. PubMed ID: 6975299
    [No Abstract]   [Full Text] [Related]  

  • 42. Th2-type CD4+ cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model.
    Fernando GJ; Stewart TJ; Tindle RW; Frazer IH
    J Immunol; 1998 Sep; 161(5):2421-7. PubMed ID: 9725239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro establishment and some properties of AKR thymoma cell lines.
    Riesenfeld I; Tufveson G; Alm GV
    Acta Pathol Microbiol Scand A; 1977 Sep; 85(5):739-44. PubMed ID: 303433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Periodic fluctuations in resistance of a myeloma tumor (MOPC-315-el) to cytotoxic T lymphocytes.
    Hale AH; Russell JH; d'Angeac AD; Panetti M; Hazelton B; Eisen HN
    Cell Immunol; 1981 Jul; 62(1):119-31. PubMed ID: 6973405
    [No Abstract]   [Full Text] [Related]  

  • 45. Selective expression of loci in th I--J region on T cell hybrids.
    Osborne BA; Goldsby RA; Herzenberg LA
    Curr Top Microbiol Immunol; 1978; 81():217-20. PubMed ID: 80306
    [No Abstract]   [Full Text] [Related]  

  • 46. A dual recognition model for cytotoxic T cells based on thymic selection of precursors with low affinity for Self H-2 antigens.
    Blanden RV; Ada GL
    Scand J Immunol; 1978 Mar; 7(3):181-90. PubMed ID: 77550
    [No Abstract]   [Full Text] [Related]  

  • 47. Role of lymphokine and antigen in the control of specific T cell responses.
    Lafferty KJ; Andrus L; Prowse SJ
    Immunol Rev; 1980; 51():279-314. PubMed ID: 7000674
    [No Abstract]   [Full Text] [Related]  

  • 48. [Activated T-lymphocytes--a mode of physiological tumor defence].
    Röllinghoff M; Wagner H
    Verh Dtsch Ges Inn Med; 1974; 80():1584-6. PubMed ID: 4548989
    [No Abstract]   [Full Text] [Related]  

  • 49. Antigen-specific molecules from murine T lymphocytes and T cell hybridomas.
    Goodman JW; Lewis GK; Primi D; Hornbeck P; Ruddle NH
    Mol Immunol; 1980 Jul; 17(7):933-45. PubMed ID: 6163975
    [No Abstract]   [Full Text] [Related]  

  • 50. Cytotoxic T cell hybridomas: generation and characterization.
    Eshhar Z; Waks T; Oren T; Berke G; Kaufmann Y
    Curr Top Microbiol Immunol; 1982; 100():11-8. PubMed ID: 6980088
    [No Abstract]   [Full Text] [Related]  

  • 51. Spleen cells from athymic mice are ineffective stimulator cells for cytotoxic responses in microcultures and in vivo.
    Moyers C; Droege W
    Cell Immunol; 1982 Aug; 71(2):282-92. PubMed ID: 6982767
    [No Abstract]   [Full Text] [Related]  

  • 52. [The role of tumor hybrid cells in antitumor immunity. II. Comparison of antigenicity of tumor hybrid cells and ascitic hepatoma cells by leukocyte migration inhibition test].
    Tong YX
    Zhonghua Zhong Liu Za Zhi; 1983 Jul; 5(4):259-61. PubMed ID: 6653340
    [No Abstract]   [Full Text] [Related]  

  • 53. Specific suppressor T cell hybridomas.
    Taniguchi M; Miller JF
    Curr Top Microbiol Immunol; 1978; 81():212-6. PubMed ID: 80305
    [No Abstract]   [Full Text] [Related]  

  • 54. Attempts to produce cytolytically active cell hybrids using EL4 and MLC spleen.
    DiPauli R; DiPauli G
    Curr Top Microbiol Immunol; 1978; 81():221-3. PubMed ID: 308441
    [No Abstract]   [Full Text] [Related]  

  • 55. Hybridization of T lymphocytes: characterization of a suppressor factor produced by a hybrid T cell line in mice [proceedings].
    Holliman A; Taussig MJ
    J Physiol; 1978 Nov; 284():5P-6P. PubMed ID: 310461
    [No Abstract]   [Full Text] [Related]  

  • 56. The measurement of cytotoxicity by the reduction of hybridoma plaque-forming cells.
    Skinner MA; Marbrook J
    J Immunol Methods; 1981; 42(2):171-7. PubMed ID: 6972415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunoglobulin gene rearrangements in hybridoma cells.
    Wilson R; Storb U; Arp B
    J Immunol; 1980 May; 124(5):2071-6. PubMed ID: 6245134
    [No Abstract]   [Full Text] [Related]  

  • 58. Characterization and functional analysis of T cell hybrids.
    Grützmann R; Hämmerling GJ
    Curr Top Microbiol Immunol; 1978; 81():188-91. PubMed ID: 567557
    [No Abstract]   [Full Text] [Related]  

  • 59. Analysis of lymphocyte surface antigen expression by the use of variant cell lines.
    Hyman R; Trowbridge I
    Cold Spring Harb Symp Quant Biol; 1977; 41 Pt 1():407-15. PubMed ID: 302193
    [No Abstract]   [Full Text] [Related]  

  • 60. Mouse monoclonal antibody against Lyt-1.1 alloantigen.
    Pierres M; Rebouah JP; Liabeuf A; Dosseto M
    J Immunogenet; 1981 Feb; 8(1):67-71. PubMed ID: 6972980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.